What this means
This is a trial that is still signing up people, so no results exist yet. It will test whether an online program helps men on hormone therapy lose weight and feel less frail.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including Oregon
The science
- Registered title
- Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- Trial ID
- NCT06011499 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Prostate Carcinoma
- What is tested
- Internet-Based Exercise Intervention, Internet-Based Diet Intervention, Education Intervention
- Sponsor
- OHSU Knight Cancer Institute
- Ages
- 18 Years to no maximum
- Dates
- First posted Aug 25, 2023 · updated May 8, 2026
Registry summary
This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.
Sites (1)
- OHSU Knight Cancer Institute, Portland, Oregon, United States